Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to $17.1 million.

  • Abvc Biopharma's Non-Current Assets rose 20507.41% to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.6 million, marking a year-over-year increase of 41198.46%. This contributed to the annual value of $1.1 million for FY2024, which is 5789.31% up from last year.
  • As of Q3 2025, Abvc Biopharma's Non-Current Assets stood at $17.1 million, which was up 20507.41% from $13.5 million recorded in Q2 2025.
  • Abvc Biopharma's 5-year Non-Current Assets high stood at $17.1 million for Q3 2025, and its period low was $644654.0 during Q2 2023.
  • Over the past 5 years, Abvc Biopharma's median Non-Current Assets value was $1.1 million (recorded in 2024), while the average stood at $3.8 million.
  • Per our database at Business Quant, Abvc Biopharma's Non-Current Assets crashed by 8035.19% in 2023 and then surged by 195754.47% in 2025.
  • Abvc Biopharma's Non-Current Assets (Quarter) stood at $959454.0 in 2021, then dropped by 22.93% to $739472.0 in 2022, then decreased by 7.2% to $686206.0 in 2023, then soared by 57.89% to $1.1 million in 2024, then surged by 1478.6% to $17.1 million in 2025.
  • Its Non-Current Assets was $17.1 million in Q3 2025, compared to $13.5 million in Q2 2025 and $13.4 million in Q1 2025.